Veracyte | VCYT - Ebitda


Veracyte reported $42.8M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Agenus USD -10.11M 19.02M Mar/2025
Agilent USD 540M 74M Sep/2025
Anika Therapeutics USD 4.54M 3.67M Dec/2025
Arrowhead Research USD 57.17M 7.03M Dec/2025
Bruker USD 110M 101.6M Mar/2026
Heron Therapeutics USD -3.88M 5.63M Sep/2024
Illumina USD 469M 137M Dec/2025
Intrexon USD -24.7M 2.92M Jun/2024
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Laboratory Of America USD 605.6M 17.5M Mar/2026
Ligand Pharmaceuticals USD 66.78M 83.54M Dec/2025
Myriad Genetics USD 14.3M 4M Dec/2025
Rigel Pharmaceuticals USD -4.17M 798K Sep/2023
Roche Holding CHF 12.68B 2.36B Jun/2024
Siemens EUR 3.56B 80M Mar/2026
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Veracyte USD 42.8M 488K Mar/2026
Waters USD 380.97M 85.83M Dec/2025